Advertisement

Ads Placeholder
Loading...

Praxsyn Corporation

PXYNPNK
Healthcare
Medical - Pharmaceuticals
$0.00
$0.00(0.00%)
U.S. Market opens in 49h 11m

Praxsyn Corporation Fundamental Analysis

Praxsyn Corporation (PXYN) shows weak financial fundamentals with a PE ratio of -0.01, profit margin of -6.96%, and ROE of -20.21%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position56.46%
PEG Ratio-0.00

Areas of Concern

ROE-20.21%
Operating Margin-2.41%
We analyze PXYN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -652.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-652.5/100

We analyze PXYN's fundamental strength across five key dimensions:

Efficiency Score

Weak

PXYN struggles to generate sufficient returns from assets.

ROA > 10%
-5.08%

Valuation Score

Excellent

PXYN trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Moderate

PXYN shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

PXYN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.65
Current Ratio > 1
1.28

Profitability Score

Weak

PXYN struggles to sustain strong margins.

ROE > 15%
-2020.70%
Net Margin ≥ 15%
-6.96%
Positive Free Cash Flow
No

Key Financial Metrics

Is PXYN Expensive or Cheap?

P/E Ratio

PXYN trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, PXYN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Praxsyn Corporation at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at 11.76 times EBITDA. This signals the market has high growth expectations.

11.76

How Well Does PXYN Make Money?

Net Profit Margin

For every $100 in sales, Praxsyn Corporation keeps $-6.96 as profit after all expenses.

-6.96%

Operating Margin

Core operations generate -2.41 in profit for every $100 in revenue, before interest and taxes.

-2.41%

ROE

Management delivers $-20.21 in profit for every $100 of shareholder equity.

-20.21%

ROA

Praxsyn Corporation generates $-5.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Praxsyn Corporation generates limited operating cash flow of $-20.36M, signaling weaker underlying cash strength.

$-20.36M

Free Cash Flow

Praxsyn Corporation generates weak or negative free cash flow of $-20.42M, restricting financial flexibility.

$-20.42M

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

PXYN converts -3747.45% of its market value into free cash.

-3747.45%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.003

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.65

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.28

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.20

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

-0.08

vs 25 benchmark

How PXYN Stacks Against Its Sector Peers

MetricPXYN ValueSector AveragePerformance
P/E Ratio-0.0128.45 Better (Cheaper)
ROE-20.21%763.00% Weak
Net Margin-695.52%-45265.00% (disorted) Weak
Debt/Equity0.650.34 Weak (High Leverage)
Current Ratio1.282795.60 Neutral
ROA-5.08%-16588.00% (disorted) Weak

PXYN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Praxsyn Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ